What's actually true in the talc lawsuit, benzene sunscreen, and acne cream cases taking over your feed
A $4.69 billion talc verdict, a benzene sunscreen recall, and a wave of acne-cream lawsuits are all over your feed. Here's what's actually verified in each.
Emily Harper
Your bathroom shelf is having a very litigious year. A talc lawsuit that started in 2018 is still making headlines. A benzene sunscreen recall from 2021 never really went away. And a wave of newer suits over acne cream and keratin shampoo are picking up steam. It's easy to see one clip on Instagram and assume every brand in your cabinet is guilty of the same thing. They're not — and the differences matter for what you actually do about it.
We pulled the court filings, the FDA petitions, and the actual lab data behind the five biggest claims making the rounds. Some hold up. One has already been thrown out. Here's what's real.
The talc lawsuit: a $4.69 billion verdict that's still not final, eight years later
In July 2018, a St. Louis jury awarded 22 women $4.69 billion — $550 million in compensatory damages, $4.14 billion in punitive — after finding that Johnson & Johnson's talc-based Baby Powder was contaminated with asbestos and caused their ovarian cancer (NPR, CNN). That's the number everyone quotes. What usually gets left out is what happened next.
In June 2020, the Missouri Court of Appeals cut the award to $2.1 billion — not because it doubted the science, but because 19 of the 22 plaintiffs weren't Missouri residents and the court found the state lacked jurisdiction over their claims (Winston & Strawn). The Missouri Supreme Court declined to review it, and in June 2021 the U.S. Supreme Court refused to hear J&J's appeal, letting the $2.1 billion verdict stand. J&J paid roughly $2.5 billion with interest (Expert Institute).
That didn't end the broader litigation — it just closed one case. J&J spent the next four years trying to use bankruptcy to cap its total talc liability, routing the claims through a subsidiary (LTL Management, then a second entity called Red River Talc) in what courts openly called a "Texas two-step." All three attempts were rejected: the Third Circuit tossed the first two LTL filings in 2023 and 2024, and in 2025 a Texas bankruptcy judge dismissed the Red River Talc case too, ruling the company wasn't actually in financial distress (JD Supra). With the bankruptcy route closed off, J&J went back to negotiating directly, and in July 2026 announced an estimated $5.5 billion global settlement to resolve the remaining talc claims — still working through finalization as of this writing (Drugwatch).
J&J has maintained throughout that its talc is safe and asbestos-free. It also quietly stopped betting on that argument at the shelf level: it discontinued talc-based Baby Powder in the U.S. and Canada in 2020, then globally in 2023, replacing it with an all-cornstarch formula (J&J press release). If you've got a bottle in your cabinet right now, check the current formula on Tallow — the ones on shelves today are the cornstarch version, not the one named in the lawsuits.
Benzene sunscreen: the 2021 recall that turned into a five-year-old, unresolved problem
This one didn't start with a lawsuit — it started with a lab. On May 25, 2021, independent testing pharmacy Valisure filed an FDA citizen petition (Docket FDA-2021-P-0497) after screening 294 sunscreen and after-sun batches from 69 companies. Benzene — a known human carcinogen with no safe exposure level — showed up in 27% of them. Fourteen lots from four brands came back above 2 parts per million, with the worst reading at 6.26 ppm (Valisure petition coverage).
The "2 ppm" figure is worth pinning down, because it's not a cosmetics rule — the FDA doesn't set a benzene limit for cosmetics generally. It's the FDA's conditional limit for benzene as a residual solvent in drug manufacturing, under circumstances where trace amounts are unavoidable (Valisure). That reference point applies here specifically because sunscreen is regulated as an over-the-counter drug in the U.S., not a plain cosmetic — one of the few beauty-aisle categories the FDA actually has real authority over. Valisure's worst readings landed at roughly three times that benchmark, which is where the "3x" figure going around actually comes from — it's a comparison to a drug-manufacturing solvent limit, not a legal cosmetics cap, and it's worth saying so.
Six weeks later, on July 14, 2021, Johnson & Johnson recalled five aerosol sunscreens under the Neutrogena and Aveeno names — Beach Defense, Cool Dry Sport, Invisible Daily, Ultra Sheer, and Aveeno Protect + Refresh. Coppertone followed with its own aerosol recall that September. Both companies still face class-action and personal-injury suits over the contamination; courts have been demanding plaintiffs prove which specific batch they used before letting individual injury claims proceed, so the economic-loss cases (people who just want refunds) are further along than the cancer-claim cases. If you use a spray sunscreen from that era, or want to check what's on shelves now, Neutrogena's current Beach Defense spray is on Tallow.
Acne cream: benzene that forms from the inside, not a contaminant
The benzoyl peroxide story is a genuinely different mechanism, and it's newer. In March 2024, Valisure filed another citizen petition, this time reporting that benzoyl peroxide — the active ingredient in most drugstore acne treatments — can chemically degrade into benzene on its own, especially at higher temperatures, rather than picking up benzene as a manufacturing contaminant the way sunscreen did (Valisure's petition). Their testing found extreme outliers: Proactiv's 2.5% cream at roughly 1,761 ppm, Target's Up & Up 2.5% cream at 1,598 ppm — hundreds of times the 2 ppm reference point. CeraVe products tested in the 5–12 ppm range (reporting on the CeraVe suits).
L'Oréal, which owns CeraVe, has been named in multiple class actions over this — the first filed by Jennifer Snow in Hawaii in March 2024, followed by others including a Louisiana suit weeks later — alleging the company sold benzoyl peroxide products without disclosing the degradation risk.
Here's the part that's easy to miss: when the FDA ran its own testing in response, the results didn't match Valisure's. In March 2025, the FDA tested 95 benzoyl peroxide products and found more than 90% had undetectable or extremely low benzene levels. Only six showed elevated readings, leading to seven voluntary recalls — La Roche-Posay, Walgreens store brand, Proactiv, SLMD, and Zapzyt products (Yale School of Medicine). CeraVe was not among them, and legal analysts have flagged the gap between Valisure's numbers and the FDA's as a real point of dispute in the pending cases, not a settled fact (Skadden). CeraVe is being sued; it hasn't been recalled. Those are two different things, and the lawsuits are still working through that gap. You can see CeraVe's acne cleanser lab data on Tallow if you want to check a specific product yourself.
DMDM hydantoin: TRESemmé's keratin shampoo, and the Suave case it rhymes with
Briefly, because we've covered this one in depth before: TRESemmé's Keratin Smooth shampoo line is facing an active class action over DMDM hydantoin, a preservative that slowly releases formaldehyde as it breaks down. Plaintiffs in a consolidated suit against Unilever and Conopco allege scalp burns and hair loss, and a related complaint claims Unilever marketed the line as "formaldehyde-free" despite the ingredient list saying otherwise. The case was still active as of 2025.
This isn't Unilever's first time here. Its Suave Professionals Keratin Infusion line went through nearly the identical fact pattern in 2012 — same preservative, same hair-loss and scalp-burn complaints, same "formaldehyde-free" marketing dispute — and it ended in a $10.2 million class settlement that the Seventh Circuit upheld in 2016 (Courthouse News). If you use TRESemmé's keratin shampoo, it's worth knowing this isn't the company's first pass at this exact argument.
One more, quickly, for completeness: L'Oréal and Maybelline also faced a lawsuit over PFAS in waterproof mascara, but that case got thrown out in September 2023 — a judge ruled the plaintiffs never proved the specific products they bought had actually been tested for PFAS. Not every scary claim survives contact with a courtroom, which is exactly why it's worth checking each one individually instead of writing off a whole shelf.
What actually changed with FDA oversight — and what didn't
The claim that "cosmetics don't need FDA approval" is still technically true, and it's the reason all of the above was even possible: unlike drugs, cosmetics in the U.S. have never needed premarket approval before hitting shelves. But that's gotten a little less true since 2022. The Modernization of Cosmetics Regulation Act (MoCRA) — the biggest expansion of FDA cosmetic authority since 1938 — now requires manufacturers to register their facilities and list their products with the FDA, report serious adverse events (hospitalization, disfigurement, and worse) within 15 business days, and, for the first time, gives the FDA the power to order a mandatory recall if a company won't do one voluntarily (Congressional Research Service, Foley & Lardner). What MoCRA still doesn't require is premarket safety testing or FDA sign-off before a product ships — which is why every case above started with an independent lab, not a regulator.
Where that leaves you
None of this means throw out your bathroom cabinet. It means the honest version of "your beauty products might contain something bad" is more specific than the Instagram version: some of these claims are backed by an actual verdict, some are still-pending litigation with disputed lab numbers, and at least one has already been dismissed in court. Treating them all the same — or all as guilty — gets you further from the truth, not closer.
The actual fix isn't reading FDA dockets every time a brand goes viral. It's checking the specific product in your hand. Tallow scans the barcode on what's already in your cabinet and shows you the lab testing and ingredient breakdown behind it — including the exact products named above — so you're not relying on a caption to tell you what's actually been found in something before you decide whether to keep using it.